Phase I – Other

1,082 trials 243 recruiting

Filter these 1,082 trials by condition, country, sponsor and more.

Open in Search →

A Trial Investigating the pain-relieving properties of Lu AG06474 in Healthy Adult Participants Ended

2023-503987-18-00 Pain 2023-10-03
Investigation of safety, tolerability and pharmacokinetics of multiple doses of NNC0113‑6856 in healthy participants, including a subset of … Ended

2023-503891-26-00 Type 2 diabetes 2023-09-29
A clinical trial to evaluate the absolute bioavailability and metabolic profile of aticaprant when administered as an oral tablet and a micr… Ended

2022-502969-19-00 Healthy Adult Participants 2023-09-27
Open label, single-center, cross-over randomized, relative bioavailability study comparing 4 new BF2.649 (pitolisant) tablet formulations ve… Ended

2023-505769-98-00 Narcolepsy 2023-09-26
PET study of changes in [11C]AZ14132516 uptake following administration of AZD7798 to healthy participants and patients with Crohn’s disease Ended

2023-505471-78-00 Crohn's Disease 2023-09-25
A study to learn about how much elinzanetant gets absorbed in the blood and how safe it is in healthy participants when taken as different t… Ended

2023-503968-16-00 Vasomotor symptoms as a sex hormone-dependent disorder 2023-09-25
A Phase 1, Open-label, Pharmacokinetic Study of TVB-2640 in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects … Ended

2023-505180-36-00 Impaired Hepatic Function The study will enroll as fol 2023-09-21
A study to learn how much elinzanetant gets into the blood, how safe it is and how it affects the body after taking single and multiple amou… Ended

2023-503864-17-00 Vasomotor Symptoms as a sex hormone-dependent disorder 2023-09-20
A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered via Levodopa Cyclops™ (test product) R… Ended

2023-504687-42-00 No therapeutic indication in the current trial with hea 2023-09-19
A Phase 1 Study of BMS-986360/CC-90001 Alone and in Combination with Chemotherapy or Nivolumab in Advanced Solid Tumors Ended

2022-500930-27-00 Solid Tumor 2023-09-15
A Translational Phase 1B, 2-Part Study to Evaluate Pharmacokinetics, Safety and Pharmacodynamics of Treatment with ATX-304 Na Salt Tablets. Ended

2023-505967-36-00 Obesity with prediabetes or type 2 diabetes mellitus 2023-09-15
Open label study to investigate patch adhesion of an Esflurbiprofen-containing patch in healthy volunteers Ended

2023-503609-12-00 patch adhesion trial with healthy subjects, therapeutic 2023-09-14
A randomized, open-label, single dose, cross-over bioavailability study evaluating the drug-drug interaction between Tritace 10, 10 mg, tabl… Ended

2023-505887-12-00 NA - study in healthy subjects 2023-09-13
A study in healthy men to test whether carbamazepine influences the amount of BI 1810631 in the blood Ended

2022-503046-50-00 Healthy volunteer trial 2023-09-11
A Study Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso‑O… Ended

2022-502546-26-00 Sickle Cell Disease 2023-09-11
A study in healthy women to test whether BI 1358894 influences the amount of a contraceptive in the blood Ended

2022-502861-78-00 Pharmacokinetic trial 2023-09-08
A study to compare how different medicines (rosuvastatin, digoxin, metformin, and furosemide) are handled by the body of healthy people and … Ended

2024-514621-29-00 1. Patients with compensated liver cirrhosis due to any 2023-09-07
A study in healthy people to test how well repeated doses of BI 3032950 are tolerated Ended

2023-503332-40-00 Healthy 2023-09-05
A study to test how well different doses of BI 1584862 are tolerated by healthy men Ended

2023-503541-54-00 Healthy volunteer trial 2023-08-28
A Study to Learn How Different Manufactured Products of the Study Medicine Called Sisunatovir are Taken Up Into the Blood When Taken on an E… Ended

2023-505228-79-00 RSV (Respiratory Syncytial Virus) 2023-08-28
A PHASE 1 STUDY TO ASSESS THE EXCRETION BALANCE, PHARMACOKINETICS, AND METABOLISM OF [14C] DC 806 IN HEALTHY MALE PARTICIPANTS. Ended

2023-505367-36-00 Healthy 2023-08-24
A Study to Learn About the Study Medication Called Etrasimod Mini Tablets, Including Its Taste, When Mixed With Applesauce, Chocolate Puddin… Ended

2023-504411-32-00 immune-mediated inflammatory disorders, including ulcer 2023-08-23
An open-label, multi-center, dose-escalation Phase Ib study to determine the recommended phase 2 dose of APN401 in patients with advanced so… Ended

2023-504281-34-00 Adult patients with advanced solid tumors 2023-08-22
A two-part, open-label study to assess the pharmacokinetics, pharmacodynamics and safety of single doses of inhaled and intravenously admini… Ended

2022-503037-63-00 Phase I, Clinical trial in healthy males and females in 2023-08-17